Do you have questions about CITI courses?


Are you currently registered or interested in taking a CITI Canada course? N2 fulfills the Helpdesk functions for all questions or queries related to CITI Canada.  Please contact shelley.king@n2canada or 519-777-7716 for assistance.

Here is a list of questions to commonly asked questions…



Exciting CITI News!

N2 is pleased to announce the release of the ICH E6 R2-GCP updated Good Clinical Practice (GCP) Basic Course. The 10-module course is now available through the Collaborative Institutional Training Initiative (CITI).

Previously 13-modules, this 10-module course discusses good clinical practice as it relates to clinical trials. The discussion is focused on the International Council for Harmonisation (ICH)-E6 (R2) guidelines and applicable regulations in Canada such as Health Canada-Division 5, and The Tri-Council Policy Statement 2.

This is significant in that N2 has worked with TransCelerate to assure that the high-quality CITI Canada GCP course accessible to N2 members meets their standards. This means if you are working with a TransCelerate affiliated company you can assure them that your CITI Canada training has formal approval and recognition from TransCelerate. Meeting TransCelerate training criteria is the latest milestone in a trend that has seen many biopharmaceutical companies as well as research networks, hospitals and universities accept the CITI Canada GCP course as their gold standard.

For more information please review the article “How to Determine if a GCP Course Meets TransCelerate BioPharma Minimum Criteria” which provides a brief overview of the TransCelerate certification.

For more CITI updates please click here.

The Canadian Institutes of Health Research Report

The Canadian Institutes of Health Research (CIHR) is committed to strengthening the clinical trials ecosystem to improve health care and health outcomes for all Canadians. CIHR is now looking to build a long-term strategy to support Canada’s clinical trials ecosystem. In the fall of 2022, CIHR launched Building the future of clinical trials, an online consultation with the research community, partners, and stakeholders involved in clinical trials. Participants were asked questions about CIHR’s role in funding clinical trials and in developing related policies and programs. Their discussions and preliminary recommendations will inform our ongoing conversations in order to shape the development of a long-term clinical trials strategy.

CIHR received a total of 44 responses from researchers, patient and citizen groups, research and health networks, government departments, and several organizations between September 28, 2022, and December 1, 2022. These 44 responses represent the collated comments from over 140 individuals, representing over 100 organizations or groups of stakeholders.

Read the Full Report

Apply for the first annual Paddi O’Hara Lecture Award

N2 is proud to announce the first annual Paddi O’Hara Lecture Award.

The selected speaker will receive a $2,500 honorarium and will be invited to give a talk on their chosen topic at the N2 annual meeting February 2021.

All applications for the 2021 Paddi O’Hara Lecture Award must be received electronically by 5:00 pm EST on January 15, 2021.

Submissions can be e-mailed to N2 at with the subject line “Paddi O’Hara Lecture Award Submission.”

Download the Application

Download Information Package

The Paddi O’Hara Annual Lecture Award has been established by the Network of Networks (N2) and Paddi’s family to honour the life of Paddi O’Hara and her contributions to N2.

Paddi was a uniquely bright and engaging person with a passion for family, friends and for her tireless work in research ethics.  Despite facing her own personal challenges, she was always ready to lend her support to people and causes she held dear.  Her generosity as a teacher and colleague led to many fruitful collaborations over the years, including her work with N2.

Paddi led the implementation of the N2-Collaborative Institutional Training Initiative (CITI) education program in Canada and served as the chair of the N2 Education Committee. Paddi’s leadership and dedication in bioethics course development were instrumental in creating the N2 CITI Canada program that is now used across Canada to support high quality ethical research practice.
This award was established in Paddi’s memory in an effort to continually shine a light on the importance of advancing ethical clinical research practice and education.  It will recognize an applicant addressing a topic in clinical research education or research ethics. The award will be granted at the N2 annual meeting to the successful applicant following a competitive application process conducted by N2.





COURSES N2 has a partnership with the Collaborative Institutional Training Initiative (CITI) to provide high-quality, web-based, TransCelerate recognized Canadian instruction on a variety of research topics. These courses promote research with human participants to be...